Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome

Blood (2010) 116 (23): 4874–4884.

https://doi.org/10.1182/blood-2009-08-239681

Published: 2010

Includes: Supplemental data

Journal Articles

Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1 , Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia

Richard C. Harvey, Charles G. Mullighan, I-Ming Chen, Walker Wharton, Fady M. Mikhail, Andrew J. Carroll, Huining Kang, Wei Liu, Kevin K. Dobbin, Malcolm A. Smith, William L. Carroll, Meenakshi Devidas, W. Paul Bowman, Bruce M. Camitta, Gregory H. Reaman, Stephen P. Hunger, James R. Downing, Cheryl L. Willman

Blood (2010) 115 (26): 5312–5321.

https://doi.org/10.1182/blood-2009-09-245944

Published: 2010

Journal Articles

Use of Genomic Technologies to Identify Novel Genetic Abnormalities and Therapeutic Targets In Acute Lymphoblastic Leukemia.

Cheryl L. Willman, MD, Huining Kang, PhD, Richard C. Harvey, PhD, I-Ming Chen, DVM, MS, Charles Mullighan, MD, James R. Downing, MD, Mary V. Relling, PharmD, Jinghui Zhang, PhD, Daniela Gerhard, PhD, Malcolm Smith, MD, PhD, Kevin K. Dobbin, PhD, Gregory Reaman, MD, Stephen Hunger, MD

Blood (2008) 112 (11): sci-8.

https://doi.org/10.1182/blood.V112.11.sci-8.sci-8

Published: 2008

Journal Articles

Identification of Novel Cluster Groups in High-Risk Pediatric B-Precursor Acute Lymphoblastic Leukemia (HR-ALL) by Gene Expression Profiling: Correlation with Clinical and Outcome Variables. a Children’s Oncology Group (COG) Study.

Richard C. Harvey, PhD, I-Ming Chen, MS, Kerem Ar, MS, Stephen P. Hunger, MD, Mignon Loh, MD, Eric C. Larsen, MD, Meenakshi Devidas, PhD, Elizabeth Raetz, MD, Gregory Reaman, MD, William L. Carroll, MD, Naomi Winick, MD, Malcolm Smith, MD, PhD, Kevin K Dobbin, PhD, Cheryl L. Willman, MD

Blood (2008) 112 (11): 2256.

https://doi.org/10.1182/blood.V112.11.2256.2256

Published: 2008

Journal Articles

Expression Profiling Identifies Novel Genetic Subgroups with Distinct Clinical Features and Outcome in High-Risk Pediatric Precursor B Acute Lymphoblastic Leukemia (B-ALL). A Children’s Oncology Group Study.

Richard C. Harvey, PhD, George S. Davidson, Xuefei Wang, PhD, Kevin K. Dobbin, PhD, Edward J. Bedrick, PhD, Carla S. Wilson, MD, PhD, Susan R. Atlas, PhD, Huining Kang, PhD, I-Ming Chen, DVM, Stephen P. Hunger, MD, Meenakshi Devidas, PhD, William L. Carroll, MD, Paul Bowman, MD, Bruce Camitta, MD, Gregory Reaman, MD, Cheryl L. Willman, MD

Blood (2007) 110 (11): 1430.

https://doi.org/10.1182/blood.V110.11.1430.1430

Published: 2007

NARROW

Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome

Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1 , Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia

Use of Genomic Technologies to Identify Novel Genetic Abnormalities and Therapeutic Targets In Acute Lymphoblastic Leukemia.

Identification of Novel Cluster Groups in High-Risk Pediatric B-Precursor Acute Lymphoblastic Leukemia (HR-ALL) by Gene Expression Profiling: Correlation with Clinical and Outcome Variables. a Children’s Oncology Group (COG) Study.

Expression Profiling Identifies Novel Genetic Subgroups with Distinct Clinical Features and Outcome in High-Risk Pediatric Precursor B Acute Lymphoblastic Leukemia (B-ALL). A Children’s Oncology Group Study.

Email alerts

ASH Publications

American Society of Hematology

Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome

Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1 , Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia

Use of Genomic Technologies to Identify Novel Genetic Abnormalities and Therapeutic Targets In Acute Lymphoblastic Leukemia.

Identification of Novel Cluster Groups in High-Risk Pediatric B-Precursor Acute Lymphoblastic Leukemia (HR-ALL) by Gene Expression Profiling: Correlation with Clinical and Outcome Variables. a Children’s Oncology Group (COG) Study.

Expression Profiling Identifies Novel Genetic Subgroups with Distinct Clinical Features and Outcome in High-Risk Pediatric Precursor B Acute Lymphoblastic Leukemia (B-ALL). A Children’s Oncology Group Study.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only